Estimate of Multiple Myeloma Patients by Line of Therapy in the USA: Population-Level Projections 2020–2025
Authors:
- 17 November 2020
- journal article
- research article
- Published by Taylor & Francis in Future Oncology
- Vol. 17 (8) , 921-930
Abstract
Aim: To report the results of a patient epidemiology model for multiple myeloma (MM) treatment by line of therapy (LOT) in the US. Materials & methods: Surveillance, Epidemiology and End Results re...Keywords
Funding Information
- GlaxoSmithKline
This publication has 13 references indexed in Scilit:
- Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional StudyClinical Lymphoma Myeloma and Leukemia, 2018
- The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry programBMC Cancer, 2018
- Treatment patterns and clinical outcomes in high‐risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi‐center retrospective studyAmerican Journal of Hematology, 2018
- The impact of age and comorbidities on practice patterns and outcomes in patients with relapsed/refractory multiple myeloma in the era of novel therapiesJournal of Geriatric Oncology, 2018
- Recent Trends in Chemotherapy Use and Oncologists’ Treatment Recommendations for Early-Stage Breast CancerJNCI: Journal of the National Cancer Institute, 2017
- Oncologists’ influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?Breast Cancer Research and Treatment, 2017
- Multiple myeloma: patient outcomes in real‐world practiceBritish Journal of Haematology, 2016
- Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic modelPharmacoepidemiology and Drug Safety, 2016
- Multiple MyelomaNew England Journal of Medicine, 2011
- Recent major improvement in long-term survival of younger patients with multiple myelomaBlood, 2008